Advertisement

Lazard Company Profile

05:38 EDT 19th June 2013 | BioPortfolio

Lazard Ltd began trading on the New York Stock Exchange on May 5, 2005 under the ticker symbol "LAZ". Lazard, the world's preeminent advisory investment bank, has offices in 16 countries around the globe. With origins dating back to 1848, the firm provides advisory services including mergers and acquisitions, asset management, and restructuring to corporations, partnerships, institutions, governments, and individuals.
Lazard is a preeminent international financial advisory and asset management firm that has long pecialized in crafting solutions to the complex financial and strategic challenges of our clients. We serve a diverse set of clients around the world, including corporations, partnerships, institutions, governments and high-net-worth individuals. We believe that what sets us apart is our dedication to: Competing on the basis of our intellectual (rather than financial) capital, which is personified by our team of highly skilled professionals
Demanding excellence and superior quality in all that we do,
Cultivating long-term, senior-level relationships with clients, through deep roots in local markets,
Linking together our local offices through a global network of industry expertise,

Contact

Phone: 1 212 632 6285
Email: richard.silverman@lazard.com


News Articles [ 158 Associated News Articles listed on BioPortfolio]

CORRECTED-SinoTech, banks to pay $20 mln to end shareholder fraud lawsuit

(In third paragraph, please read Lazard Capital Markets, not Lazard Ltd.)

Amicus Therapeutics' Management Discusses at Lazard Capital Markets Healthcare Conference (Transcript)

Amicus Therapeutics, Inc. (FOLD) Lazard Capital Markets Healthcare Conference Call November 14, 2012 3:30 pm ET Executives William D. "Chip" Baird, III – Chief Financial Officer John F. Crowley...

Hansen Medical's CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)

Hansen Medical, Inc. (HNSN) Lazard Capital Markets Healthcare Conference Call November 13, 2012 1:30 pm ET Executives Bruce J Barclay – President and Chief Executive Officer Analysts Karen C...

ImmunoGen's Management Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)

ImmunoGen, Inc. (IMGN) Lazard Capital Markets 9th Annual Healthcare Conference Transcript November 14, 2012 3:00 PM ET Executives Greg Perry - Chief Financial Officer Analysts Ryan Martins - L...

Insmed's CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)

Insmed Incorporated (INSM) Lazard Capital Markets Healthcare Conference Call November 13, 2012 10:30 ET Executives Will Lewis - President and Chief Executive Officer Analysts James Cole - Laza...

Insmed's CEO Hosts Lazard Capital Markets Healthcare Conference (Transcript)

Insmed Incorporated (INSM) Lazard Capital Markets Healthcare Conference Call November 13, 2012 10:30 ET Executives Will Lewis - President and Chief Executive Officer Analysts James Cole - Laza...

GTX's CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)

GTX, Inc. (GTXI) Lazard Capital Markets 9th Annual Healthcare Conference November 13, 2012 10:00 AM ET Executives Mitch Steiner – CEO Analysts Ryan Martin – Lazard Capital Markets Prese...

Affymax's CEO Presents at Lazard Capital Markets Healthcare Conference (Transcript)

Affymax, Inc. (AFFY) Lazard Capital Markets Healthcare Conference November 14, 2012 1:00 PM ET Executives John Orwin – CEO Analysts Meredith Cheng – Lazard Capital Markets Presentation...

Drugs and Medications [0 Results]

None

PubMed Articles [ 1 Associated PubMed Articles listed on BioPortfolio]

Early complications and symptoms of cerebellopontine angle tumor surgery: a prospective analysis.

Our objective is to prospectively report very early complications and outcomes of cerebellopontine angle (CPA) surgery. Between January and August 2007, 72 patients were operated on by different trans...

Clinical Trials [0 Results]

None

Companies [ 2 Associated Companies listed on BioPortfolio]

Lazard Capital Markets

Lazard provides a full range of financial advisory services to a diverse group of clients world-wide. Lazard Technology Partners is a venture capital firm dedicated to providing investors with superio...

Lazard

Lazard Ltd began trading on the New York Stock Exchange on May 5, 2005 under the ticker symbol "LAZ". Lazard, the world's preeminent advisory investment bank, has offices in 16 countries around the gl...

More Information about "Lazard" on BioPortfolio

We have published hundreds of Lazard news stories on BioPortfolio along with dozens of Lazard Clinical Trials and PubMed Articles about Lazard for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lazard Companies in our database. You can also find out about relevant Lazard Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement